National 12th Five-Year Plan Major New Drug Creati
In 2008, COPEN won the national special project for major new drug creation, and completed the acceptance in 2012. In 2010, Aniline Lofen Injection won the special project of national major new drug creation, and the acceptance was completed in 2014. In 2013, it jointly undertook the national major new drug creation project "New Drug Creation Based on the Structure and Function of GPCR" with four units including Shanghai Institute of Pharmacy, Chinese Academy of Sciences.
Company profile
Guangdong Zhongke Pharmaceutical Research Co., Ltd., established in 2005, is located in Guangzhou International Business Incubator, a high-tech enterprise. Its main business is the research and development of innovative small molecule chemical drugs. The company undertakes and completes two national major new drug creation projects, and jointly completes two national major new drug creation projects. In 2016, we jointly completed the national major new drug creation project "New Drug Creation Based on GPCR Structural Transformation" with Shanghai Institute of Pharmacy, Chinese Academy of Sciences, Peking University, etc., and undertook and completed two major science and technology projects in Guangdong, two major science and technology projects in Guangzhou, one national innovation fund, more than 30 patent authorizations, three clinical approvals of Class 1.1 new drugs, and four achievements of Class 1 new drugs, with a total amount of 171 million yuan.More
Products
Expand investment in product research and build a new retail platform, etc., to promote the company to be influential.
